Joshua Zeidner: Subset analyses from QUAZAR study
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about a recent paper by Hartmut Döhner et al. titled “Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine” published in ASH Publications.
Authors: Hartmut Döhner, Andrew H. Wei, Gail J. Roboz, Pau Montesinos, Felicitas R. Thol, Farhad Ravandi, Hervé Dombret, Kimmo Porkka, Irwindeep Sandhu, Barry Skikne, Wendy L. See, Manuel Ugidos, Alberto Risueño, Esther T. Chan, Anjan Thakurta, C.L. Beach, Daniel Lopes de Menezes.
Joshua Zeidner commented on X sharing this paper:
“Leukemia Journal Club Happy Hour tackled maintenance therapy with oral Azacitidine in NPM1 mutated AML patients- subset analyses from QUAZAR study- Great discussion with colleagues over.” ․
Source: Joshua Zeidner/X